NATHAN B GREEN DO NPI 1679563936

NPI Details

Nathan B Green, DO is a hematology and oncology internal medicine in Lincoln, NE with 27 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Nathan B Green, DO NPI is 1679563936. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: DES MOINES UNIVERSITY OF OSTEOPATHIC MEDICINE AND HEALTH SCIENCES
Graduation Year:1998

The provider's business location address is:

4101 TIGER LILY RD STE 100
LINCOLN, NE
ZIP 68516-587
Phone: (402) 420-7000
Fax: (402) 420-6969

The NPI 1679563936 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg (HCPCS:Q5116)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Magnesium level (HCPCS:83735)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes (HCPCS:97110)
• Ct scan of chest with contrast (HCPCS:71260)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Unclassified drugs (HCPCS:J3490)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Urinalysis, manual test (HCPCS:81002)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Phosphate level (HCPCS:84100)
• Red blood count, manual test (HCPCS:85044)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Ct scan of chest without contrast (HCPCS:71250)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Injection of drug or substance into vein (HCPCS:96374)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Ct scan of abdomen with contrast (HCPCS:74160)

The enumeration date for this NPI number is 10/26/2005 and was last updated on 3/16/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.